Jerusalem Pharmaceuticals Co. Ltd. (PEX:JPH)

Market Cap	48.31M
Revenue (ttm)	26.50M
Net Income (ttm)	2.91M
Shares Out	18.00M
EPS (ttm)	0.16
PE Ratio	16.54
Forward PE	n/a
Dividend	0.07 (2.65%)
Ex-Dividend Date	May 21, 2024

Volume	1,000
Average Volume	2,745
Open	3.780
Previous Close	3.750
Day's Range	3.780 - 3.780
52-Week Range	n/a
Beta	0.11
RSI	56.69
Earnings Date	Mar 27, 2025

About Jerusalem Pharmaceuticals

Jerusalem Pharmaceuticals Co. Ltd. develops, manufactures, and markets pharmaceutical products in Palestine, the Middle East, North Africa, and internationally. It offers range of over-the-counter, prescription pharmaceutical, and nutritional supplements products. The company produces approximately 300 pharmaceutical products in various dosage forms, such as tablets, capsules, sterile injectables, suspensions, syrups, powders, suppositories, ovules, creams, ointments, and ear and nose drops, as well as solutions. It also produces detergent, cos...

• Industry: Pharmaceutical Preparations
• Founded: 1969
• Employees: 523
• Stock Exchange: Palestine Stock Exchange
• Ticker Symbol: JPH

Financial Performance

In 2023, Jerusalem Pharmaceuticals's revenue was $39.65 million, a decrease of -14.06% compared to the previous year's $46.14 million. Earnings were $6.96 million, a decrease of -3.02%.

Financial numbers in USD